85.79 USD
↗ 1.90 (2.27%)AT CLOSE (11:59 AM EDT)
Inhibrx Biosciences, Inc. Common Stock
INBXNASDAQ • USD
85.28
↘ 0.51 (0.59%)
POST MARKET (AS OF 07:34 PM EDT)
Post Market
AS OF 07:34 PM EDT
85.28
↘ 0.51 (0.59%)
Market: CLOSED
INBX is currently priced at $85.43. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (618.9%) and a bullish Golden Cross on the moving averages. Furthermore, INBX is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Aug 6, 2026.
Open?$83.83
High?$87.74
Low?$83.83
Prev. Close?$83.89
Volume?87.7K
Avg. Volume?292.3K
VWAP?$85.27
Rel. Volume?0.30x
Bid / Ask
Bid?$57.32 × 100
Ask?$99.75 × 100
Spread?$42.43
Midpoint?$78.54
Valuation & Ratios
Market Cap?1.2B
Shares Out?14.7M
Float?9.3M
Float %?63.3%
P/E Ratio?N/A
P/B Ratio?-58.51
EPS?-$8.87
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
Themes
Employees
110
Market Cap
1.2B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2024-05-28
Address
11025 N. TORREY PINES ROAD, SUITE 140
LA JOLLA, CA 92037
Phone: (858) 795-4220
LA JOLLA, CA 92037
Phone: (858) 795-4220
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?4
Momentum?50
Short Sent.?36
Piotroski F-Score?0/9Weak
Altman Z-Score?0.22Distress
Confidence?54%Low
Short InterestSqueeze Risk
Short % of Float?36.95%Squeeze Risk
Short Interest?3.4M
Days to Cover?9.0
Free Float9.3M
Avg Daily Volume379.9K
Settlement Date2026-07-15
Financial Health
Current Ratio?6.46Strong
Quick Ratio?6.46Strong
Cash Ratio?6.10Strong
Debt/Equity?-8.32Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-58.51CHEAP▾
S&P97
P/S?946.74HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-10.3CHEAP▾
S&P97
EV/Sales?957.00HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?618.9%STRONG▾
Peers50
S&P97
ROA?-70.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-131935000
Enterprise Value?$1.2B
Fundamentals ratios updated end of day